A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis
Clinical trial NCT06478706 · COMPLETED
Trial details
- NCT number
- NCT06478706
- Sponsor
- Enterprise Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-26
- Primary completion
- 2025-11-14
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.